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Abstract: Helicobacter pylori is one of the most successful human pathogens, which 
colonizes the mucus layer of the gastric epithelium of more than 50% of the world’s 
population. This curved, microaerophilic, Gram-negative bacterium induces a chronic 
active gastritis, often asymptomatic, in all infected individuals. In some cases, this gastritis 
evolves to more severe diseases such as peptic ulcer disease, gastric adenocarcinoma, and 
gastric mucosa-associated lymphoid tissue lymphoma. H. pylori has developed a unique set 
of factors, actively supporting its successful survival and persistence in its natural hostile 
ecological niche, the human stomach, throughout the individual’s life, unless treated. In the 
human stomach, the vast majority of H. pylori cells are motile in the mucus layer lining, 
but a small percentage adheres to the epithelial cell surfaces. Adherence to the gastric 
epithelium is important for the ability of H. pylori to cause disease because this intimate 
attachment facilitates: (1) colonization and persistence, by preventing the bacteria from 
being eliminated from the stomach, by mucus turnover and gastric peristalsis; (2) evasion 
from the human immune system and (3) efficient delivery of proteins into the gastric cell, 
such as the CagA oncoprotein. Therefore, bacteria with better adherence properties 
colonize the host at higher densities. H. pylori is one of the most genetically diverse 
bacterial species known and is equipped with an extraordinarily large set of outer 
membrane proteins, whose role in the infection and persistence process will be discussed in 
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this review, as well as the different receptor structures that have been so far described for 
mucosal adherence. 
Keywords: bacterial adherence; adhesin; receptor; virulence; gastric disease; outer 
membrane protein; Lewis antigen 
 
1. Introduction: Helicobacter pylori—A Successful Pathogen 
About 30 years ago, Barry Marshall and Robin Warren reported the isolation and culture of a spiral 
bacterial species from the human stomach [1]. Helicobacter pylori previously named Campylobacter 
pyloridis is a curved microaerophilic Gram-negative bacterium, 2 to 4 μm long with a diameter of  
0.5 to 1 μm. This spiral-shaped bacillus is highly motile due to its unipolar bundle of two to six 
sheathed flagella and it colonizes the mucus layer of the gastric epithelium of humans. The bacterium 
migrated out of Africa along with our ancestors and has been intertwined with our species for at least 
two hundred thousand years [2]. While not as deadly as some bacteria, H. pylori is the most successful 
pathogen in human history since it infects up to half of the world’s population. The prevalence of  
H. pylori infection is the highest in developing countries (up to 100%) where risk factors are mainly 
low socioeconomic conditions including large family size, while decreasing in Western countries  
(10%–60%). The most common routes of H. pylori transmission are oral-to-oral and fecal-to-oral 
contact. Parents and siblings seem to play a major role in transmission.  
Acquisition of H. pylori infection occurs predominantly in childhood, with more severe 
gastroduodenal diseases appearing mostly during adulthood. Although H. pylori infection always 
causes a chronic active gastritis, the majority of infected individuals (~85%) remain asymptomatic 
throughout life. In some cases, this gastric inflammation may evolve toward more severe diseases such 
as duodenal or gastric ulcers, gastric mucosa-associated lymphoid tissue (MALT) lymphoma or  
non-cardia gastric adenocarcinoma. H. pylori infection was classified as a type I carcinogen in 1994 by 
the International Agency for Research on Cancer (World Health Organization) [3]. Indeed, H. pylori 
infection is the main risk factor in up to 92% of gastric cancers [4] and this cancer is the fourth most 
common and second most deadly cancer worldwide, with approximately 740,000 deaths per year. 
Studies have also associated H. pylori infection with diverse extragastric nonmalignant diseases [5].  
In the absence of an effective vaccine, antibiotic treatment cures peptic ulcer disease and gastric 
MALT lymphoma permanently (when the treatment is given before the MALT lymphoma becomes 
autonomous) while gastric adenocarcinoma is difficult to prevent unless it is found at an early  
stage [6]. H. pylori infection can be difficult to treat and requires the combined intake of a proton 
pump inhibitor with amoxicillin and one of two antibiotics, clarithromycin or metronidazole [7]. More 
virulent H. pylori isolates harbour numerous well-known adhesins (BabA/B, SabA, AlpA/B, OipA and 
HopZ), the vacuolating cytotoxin VacA and the oncoprotein CagA. The cagA gene belongs to the cag 
pathogenicity island (PAI), which encodes a type IV secretion system (T4SS), a needle-like pilus 
device that delivers effector proteins such as the CagA oncoprotein into the cytoplasm of gastric 
epithelial cells (for review see [8] and references cited therein). 
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The adherence of H. pylori to the mucus layer of the gastric epithelium plays an important role in 
the initial colonization and persistence of the bacteria in the human stomach during decades or for an 
entire lifetime. H. pylori colonization of the stomach elicits humoral and cellular immune responses 
which in most cases do not result in bacterial clearance. The bacterium has developed a unique set of 
factors, actively supporting its successful survival and persistence in its natural hostile ecological 
niche, the human stomach, throughout the individual’s life, unless treated. The bacterium is one of the 
most diverse and variable bacterial species known, constituting a valuable advantage to evade the host 
immune system. Almost every isolate from unrelated patients appears to have a unique “fingerprint”. 
Moreover, individuals can be colonized with multiple strains, and strains have been shown to evolve 
during chronic colonization. Not only does almost every infected person carry his/her own individual 
H. pylori strain, but strains can undergo genetic alteration in vivo, driven by an elevated mutation rate 
and an extensive exchange of genetic material [9,10], leading to free recombination of H. pylori genes. 
These phenomena result in the plasticity of the expression profile of H. pylori, also affecting surface 
proteins such as the outer membrane proteins (OMPs) [11], and suggest that H. pylori rapidly adapts to 
individual hosts; for review see [12] and references cited therein. In fact, it was recently demonstrated 
that short-term mutation rates in H. pylori could be quite fast, partially overlapping with those of 
viruses [13], with each strain of these hypermutable bacteria acting as a quasispecies [14]. The genetic 
variability of H. pylori affects housekeeping genes, virulence genes, lipopolysaccharide (LPS) and 
numerous OMP encoding genes, thus contributing to host adaptation, persistence and immune response 
evasion, giving rise to chronic inflammatory reactions. This review presents the recent progress in 
characterizing the role of the various Lewis-like antigens and adhesins in the interaction with host cell 
factors. The role of these interactions in bacterial colonization and pathogenesis is discussed. 
2. Helicobacter pylori Adherence-Associated Molecules 
2.1. Lipopolysaccharide (LPS) 
LPS is the major component of the bacterial cell wall of Gram-negative bacteria. It is an organic 
compound found in the outer leaflet of outer membranes which contributes to the structural integrity of 
the bacteria and protects the membrane. Similar to other Gram-negative bacteria, the LPS of H. pylori 
is essential for the bacteria’s survival. The LPS of H. pylori consists of an O-specific polysaccharide 
chain, a core oligosaccharide, and a lipid part called lipid A, embedded in the outer membrane. While 
LPS is often highly toxic for the host, that of H. pylori is low in activation of the host immunological 
responses [15]. 
The O-antigen of H. pylori LPS contains different human Lewis-like antigens, including Lewis 
(Le)x, Ley, Lea and Leb, which are also expressed in gastric epithelial cells [16]. It was hypothesized 
that these H. pylori LPS Lewis-like antigens could play a role in adherence to gastric epithelial cells in 
a in a Lewis-antigen-dependent manner, more specifically via Lex. Moreover, since they undergo 
phase variation and antigenic variation within a single strain, this would provide the bacteria with a 
dynamic adherent phenotype [17–19]. Several studies support the role of LPS as an adherence factor of 
H. pylori. In one study, a monoclonal antibody that inhibited H. pylori adherence to gastric epithelial 
cells by up to 75% was shown to target the LPS possibly through the O-antigen Lex portion [20]. More 
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recently, the receptor recognized by the O-antigen side-chain of H. pylori LPS was identified as being 
a host β-galactoside-binding lectin, galectin-3 [21]. This study also showed that expression of  
galectin-3 is up regulated by gastric epithelial cells following adherence of H. pylori, suggesting that, 
in addition to colonization, this lectin also plays a role in the host response to infection. 
Data from other studies indicate however that Lewis-like antigens seem to only have a limited role 
in bacterial adherence, which is most likely overcome by the strong adherence phenotype mediated by 
H. pylori adhesins [22,23]. 
2.2. Outer Membrane Proteins 
The OMP profile of H. pylori strains differs significantly from that of other Gram-negative  
species as no major OMPs predominate, rather multiple lower-abundance OMPs are observed [24].
Approximately 4% of the H. pylori genome encodes an extraordinary large set of OMPs (~64 OMPs) 
divided into five paralogous gene families[24] (Figure 1) and this unusual set of OMPs may be a 
reflection of the adaptation of H. pylori to the unique gastric environment where it is found. The 
largest family is Family 1, comprised of the Hop (for H. pylori OMP, 21 members) and Hor (for Hop 
related, 12 members) proteins. Families 2 and 3 comprise the Hof (for Helicobacter OMP, 8 members) 
and Hom (for Helicobacter outer membrane, 4 members) proteins, respectively. Families 4 and 5 are 
composed of iron-regulated OMPs (6 members) and efflux pump OMPs (3 members), respectively. 
Other OMPs (~10 members) were not included in these families [24]. 
Members of the Hop family share highly similar or identical sequences at their amino and carboxyl 
termini and include porins [25,26] and several known or predicted H. pylori adhesins which promote 
binding to the gastric epithelium [27,28]. In addition, another OMP from the third family, HomB, was 
shown to be involved in H. pylori adherence [29]. 
The level of the expression of H. pylori OMPs can be altered and regulated by several mechanisms, 
of which the most important are: gene conversion and gene duplication, regulation by phase variation 
and allelic variation. Several examples of these mechanisms are described in the paragraphs below. 
2.2.1. BabA 
The major H. pylori adhesin is the blood group antigen-binding adhesin A, named BabA or HopS or 
OMP28 (~80 kDa), which was the first identified adhesin in H. pylori; for review see [30,31] and 
references cited therein. BabA, mediates the binding of the bacterium to the fucosylated Lewis b blood 
group antigen, Leb [27,32] and related terminal fucose residues found on blood group O (H antigen), A 
and B antigens [33] which are expressed on the surface of mucins (MUC1 and MUC5B) and gastric 
epithelial cells, Leb being the dominant antigen in the gastric mucosa [34]. BabA binds to blood group 
determinants on both type 1 and type 4 core chains [35]. BabA adhesin also binds to the salivary 
mucin MUC5B, a proline-rich glycoprotein, and to the non-mucin glycoprotein gp-340 [36,37]  
(Table 1). 
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Figure 1. Phylogenetic analysis of the large the set of outer membrane proteins identified 
in Helicobacter pylori. 
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The five major families of outer membrane proteins (OMP) previously reported [24] are represented. The 
OMP gene sequences provided from the H. pylori strain J99 [24], except for the babC gene (absent in the J99 
strain) provided from the 26695 strain. Family 1 (blue) comprises 21 members named Hop (21 members) and 
Hor (12 members) proteins. Families 2 (red) and 3 (pink) comprise the Hof (8 members) and Hom (4 
members) proteins, respectively. Families 4 (green) and 5 (red) are composed of iron-regulated OMPs (6 
members) and efflux pump OMPs (3 members), respectively. The 10 other non-classified OMPs are not 
included in the phylogenetic tree [24]. The duplicated Hop proteins (HopJ/K and HopM/N) were not 
differentiated and are each visualized as one line. Neighbour-joining phylogenetic tree topologies of H. pylori 
OMP genes were constructed using the MEGA (Molecular Evolutionary Genetics Analysis) 5.1 software [38], 
on the basis of distances estimated using the Maximum Composite Likelihood model [39]. Branching 
significance was estimated using bootstrap confidence levels by randomly resampling the data 1,000 times 
with the referred evolutionary distance model. The branch length index is represented below the tree. * babC 
gene sequence provided from the H. pylori 26695 strain. Hop, Helicobacter pylori OMP; Hor, Hop related; 
Hof, Helicobacter OMP, Hom, Helicobacter outer membrane. 
Table 1. Helicobacter pylori adhesins and their receptors. 
Adhesins Receptors identified References 
BabA fucosylated Lewis b histo-blood group antigen, Leb and H1 [27,32] 
BabA 
terminal fucose residues on blood group O (H antigen), A and 
B antigens 
[33] 
BabA salivary nonmucin glycoprotein gp-340 [37] 
BabA salivary mucin MUC5B * and proline-rich glycoprotein [36,37] 
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Table 1. Cont. 
Adhesins Receptors identified References 
SabA sialyl-dimeric-Lex [28] 
SabA salivary mucin MUC7, MUC5B * [36,37] 
SabA 
salivary glycoproteins (carbonic anhydrase VI, secretory 
component, heavy chain of secretory IgA1, parotid secretory 
protein and zinc-α2-glycoprotein) 
[37] 
SabA sialylated moieties on the extracellular matrix protein laminin [36] 
SabA sialylated structures on the surface of erythrocytes [40] 
SabA sialylated carbohydrates on neutrophils  [41] 
AlpA laminin [42,43] 
AlpB laminin [42,43] 
An additional unidentified bacterial surface component (different from BabA and SabA) also mediates the 
binding to unknown receptor moieties of fibronectin and lactoferrin [36]; * MUC5B carries both fucosylated 
blood group antigens and α2–3-linked sialic acids. 
BabA adhesin has closely related paralogs (Figure 1), BabB (HopT or OMP19) and BabC (HopU or 
OMP9), whose function have not yet been determined. All of these genes present extensive 5' and 3' 
homology, in particular babA and babB [44], suggesting that the middle variable region of BabA most 
likely encodes the specific adhesin function. Five different allele groups of babA (AD1 to AD5) and 
three different allele groups of babB (BD1 to BD3) were observed within this variable region, none of 
these alleles being a determining factor in Leb binding of H. pylori strains [45]. Phylogenetic analysis 
revealed that the allelic groupings of babA and babB are independent of one another and that, for both, 
geographic variation is present [45]. Although babA/babB 5' and middle regions showed strong 
interstrain similarity, the 3' segments revealed strong intrastrain similarity, indicative of concerted 
evolution. This segment also demonstrates geographic clustering among H. pylori strains [44]. BabA 
expression is regulated both at transcriptional and translational levels [44,46–51]. babA, babB and 
babC paralogs can be present at multiple loci, with babA and babB usually present at loci A and B, 
respectively, while the locus C is rarely occupied [46,52,53]. Gene conversion (see Section 3 below) 
frequently occurs between the loci A and B, most likely by RecA-dependent intragenomic recombination 
between complementary loci [44] leading to chimeric babB/A and babA/B genes [46–49]. For 
example, non Leb binding strains can regain Leb binding activity by recombination into the babB locus 
leading to the BabB/A chimera able to bind Leb [47]. In vivo loss of BabA expression and Leb binding 
was also reported in animal models [48,50,51]. The loss of BabA adherence is due to (1) the modification 
of six amino acid residues critical for the binding to fucosylated blood group antigens [50], (2) 
nucleotide(s) substitution, deletion (up tp 84 bp) or insertion (1 bp) within various portions of the 
babA gene resulting in a truncated BabA translation product [51] or (3) phase variation through a 
slipped strand mechanism
SSM) based on the number of Cysteine-Threonine (CT) dinucleotide 
repeats in the 5' region of the gene [27,46,48,50]. These CT repeats are probably the result of 
chromosomal translocation events. Initially, two babA “alleles” were reported; babA2 allele is 
expressed and involved in the Leb binding activity, while the rarest babA1 is not expressed due to a  
10 bp deletion in its signal peptide sequence [27] that eliminates its translational initiation codon and 
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also due to the presence of four additional nucleotides between the 10- and 35-sites of the babA1 
promoter, diminishing the strength of the promoter [47]. 
Both in vitro and in vivo experiments revealed that BabA-mediated adherence to Leb on the 
epithelial surface is a potentiator of the H. pylori T4SS secretion system activity, thus triggering the 
transcription of genes which enhance inflammation, development of intestinal metaplasia, and 
associated precancerous transformations [54]. BabA binding to Leb is also important for the induction 
of DNA double-strand breaks and a DNA damage response in host cells in a manner independent of 
VacA, γ-glutamyl transpeptidase and the cag PAI [55]. 
The presence of babA is associated with cagA and vacA toxigenic s1 alleles. However, most  
PCR-based methods currently used to determine the babA status do not evaluate the babA 
transcriptional regulation mechanisms (see above) that could result in loss of BabA adherence [56]. A 
few studies evaluated the BabA status by immunoenzymatic-based methods and Leb binding activity. 
They nevertheless confirmed that the BabA-positive status of infecting strains is associated with CagA 
and VacAs1 and the presence of intestinal metaplasia and degenerative alterations in human biopsies [57]. 
BabA-positive status is also closely associated with severe clinical outcomes [58]. Surprisingly, a 
small group of strains producing low levels of BabA and lacking Leb binding activity were more likely 
to be associated with increased mucosal inflammation and severe clinical outcomes than BabA-positive 
strains with Leb binding activity [56]. The underlying mechanism remains unclear and further studies 
are necessary to investigate the functional coordination of the BabA-receptor network during 
interaction of H. pylori with the gastric epithelium [30]. 
2.2.2. SabA 
The sialic acid-binding adhesin, SabA or HopP or OMP17 (~70 KDa), is the second most well 
characterized adhesin of H. pylori; for review see [59] and references cited therein. Upon H. pylori 
infection and the resulting mucosal inflammation, the sialyl-dimeric-Lewis x (Lex) glycosphingolipid 
is upregulated and SabA mediates the binding of the bacterium to the sialyl-dimeric-Lex [28]. SabA 
adhesin also participates with BabA in the binding of H. pylori to a salivary mucin MUC5B, but to a 
lesser extent [36,37] (Table 1). 
SabA has a closely related paralog, SabB (HopO, OMP16) [24] (Figure 1). The 5' and 3' ends of the 
sabA gene share the highest nucleotide identity with two genes, sabB [24] and another OMP, hopQ 
(OMP27) [60], whose function has not yet been determined; both may also be involved in H. pylori 
adherence [61,62]. Variability in copy number and locus of sabA and its paralogs, sabB and hopQ, 
also occurs among clinical H. pylori isolates [60]. Gene conversion is a mechanism for H. pylori to 
regulate the amount of SabA on the bacterial surface and adherence to mouse gastric tissue. Gene 
conversion mainly results from intragenomic recombination and occurs in vitro at a similar rate at both 
the sabA and sabB loci but at a lower rate at the hopQ locus. The pH appears to be another regulation 
mechanism of sabA expression. Indeed, sabA mRNA and SabA expression levels are decreased under 
acidic conditions [63,64]. 
The sabA gene is one of the most divergent genes in the H. pylori genome [65] and is also regulated 
at transcriptional level by several mechanisms. Indeed, dinucleotide CT repeats present in the 5' coding 
region of sabA regulate its expression by phase variation through SSM [61,64] and the sabA promoter 
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region modulates its transcriptional activity through a variable homopolymeric thymidine tract [66]. 
The frequent “on/off” switch of SabA expression suggests that SabA expression can rapidly respond to 
changing conditions in the stomach. Molecular-based methods currently used to analyze the CT 
repeats do not correlate with SabA production defined by immunoblot [59], probably because of the 
frequent “on/off” switches. SabA positive status was inversely related to the ability of the stomach to 
secrete acid, suggesting that its expression may be regulated by changes in acid secretion and/or in 
antigens expressed by the atrophic mucosa [64]. 
The interaction between SabA and its ligand enhances the colonization density of H. pylori in 
patients lacking gastric Leb [67]. Moreover, H. pylori modulates the expression of the SabA ligand, the 
sialyl-dimeric-Lex, in human gastric cell lines via the induction of a specific glycosyltransferase, β3 
GlcNAc T5 (β3GnT5), involved in the biosynthesis of Lewis antigens, thereby strengthening the 
epithelial attachment necessary to achieve successful colonization [68]. 
SabA has also been identified as a haemagglutinin which binds to sialylated structures found  
on the surface of erythrocytes, and there is a good correlation among strains between sialic acid 
dependent haemagglutination and sialyl Lex binding [40]. A high level of polymorphism in sialyl 
binding properties, similar to that observed for BabA, was reported among clinical H. pylori isolates, 
which suggests that SabA adapts to its host depending on the mucosal sialylation pattern of the 
infected individual [40]. 
Arrays and proteomic studies revealed that SabA also mediates the binding of H. pylori to sialylated 
moieties on the extracellular matrix protein laminin [36] and to salivary glycoproteins, including 
MUC7, carbonic anhydrase VI, secretory component, heavy chain of secretory IgA1, parotid secretory 
protein and zinc-α2-glycoprotein [37]. SabA was also found to interact with BabA in complexes that 
could be potentially implicated in the development of malignant diseases [69]. 
SabA-positive status was associated with gastric cancer, intestinal metaplasia, and corpus atrophy in 
Western strains [61] but not in Asian strains [67], suggesting differences between SabA and clinical 
outcome. Upon H. pylori induced gastritis, neutrophils and monocytes infiltrate into the gastric 
mucosa. SabA of nonopsonized H. pylori strains specifically binds to neutrophils through sialylated 
carbohydrates. As a consequence, the stimulated neutrophils produce reactive oxygen species  
causing oxidative damage of the gastric epithelium, demonstrating that SabA is nevertheless a true 
virulence factor [41]. 
2.2.3. AlpA, AlpB 
The adherence associated lipoproteins AlpA (HopC or OMP20, ~56 kDa) and AlpB (HopB or 
OMP21, ~57 kDa) are encoded by highly homologous adjacent genes, alpA and alpB [24,70]. Both 
lipoproteins were found interacting in a H. pylori membrane complex [69,71] and are involved in 
gastric colonization [72]. Indeed, the corresponding mutants did not infect the stomachs of guinea pigs 
and Mongolian gerbils [73,74] and poorly colonized the stomachs of C57BL/6 mice [75]. AlpA and 
AlpB are essential in the adherence of the bacterium to human gastric tissue in a different pattern  
than that observed for the BabA-mediated adherence, suggesting that a different receptor may be 
involved [42]. Both lipoproteins contribute to host laminin binding and influence gastric inflammation 
in gerbils; the expression of plasmid-borne alpA or alpB confers laminin-binding ability to 
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Escherichia coli [43]. No other host binding partner or receptor has yet been identified. In contrast to 
many other OMPs that are produced at extremely variable rates, AlpA and AlpB proteins are strongly 
coproduced and seem to be expressed by all clinical isolates, supporting their essential function [11]. 
The protein expression level of AlpA is nevertheless upregulated in response to oxidative stress [76]. 
AlpA and AlpB induce gastric injury by modulating proinflammatory intracellular signalling cascades 
upon infection [75]. However, discrepant results regarding the inflammatory effect of the alpAB  
locus were obtained after infection of mice and gerbils [43,75]; the AlpA-AlpB induced interleukin-8 
(IL-8) secretion seems to be related to the isolate’s geographic origin [75]. The fact that both  
these proteins seem to be constitutively expressed by all H. pylori isolates and are recognized 
specifically by sera from H. pylori-infected patients [71,77] makes these proteins attractive targets for 
the vaccine design [78,79]. 
2.2.4. OipA 
The outer inflammatory protein A (OipA, HopH or OMP13 ~34 kDa) was initially identified as a 
surface protein which promotes in vitro IL-8 secretion in a T4SS-independent manner and heightens 
gastric inflammation in vivo [80,81]. OipA regulates IL-8 secretion through PI3K/Akt and this 
regulation is dependent on FoxO1/3a inactivation [82]. However, the role of OipA in inflammation is 
controversial. Indeed, hopH mutagenesis did not alter epithelial IL-8 secretion in vitro [83] or 
inflammation in Mongolian gerbils [84]. While the OipA host receptor remains unknown, predicted 
exposed amino acid sequences were determined in silico [85] and will be useful in finding its 
receptor(s). Indeed, there is no doubt that OipA is involved in bacterial adherence to gastric cells  
in vitro [83]. The hopH gene does not have highly similar paralogs and is quite distant from other hop 
genes (Figure 1). OipA expression is regulated by phase variation within a CT dinucleotide repeat 
motif located in the 5' region of the hopH gene [80,86]. OipA “on”-status is significantly associated 
with more severe gastric diseases (duodenal ulcer and gastric cancer), high H. pylori density, and 
severe neutrophil infiltration [53,64,84,87], probably because of its association with other virulence 
factors or increased bacterial adherence and colonization [83]. The strong link between the OipA  
“on”-status and cagA suggests that OipA may contribute to the fitness of cagA-positive strains  
in vivo [53,83]. OipA is involved in H. pylori-induced focal adhesion kinase activation and cytoskeletal 
reorganization of gastric epithelial cells in the early stages of H. pylori infection [88]. Isogenic oipA 
mutants significantly reduce the phosphorylation of paxillin, a focal adhesion associated adaptor 
protein involved in the regulation of H. pylori-mediated gastric epithelial cell motility, and also actin 
stress fiber formation [89]. Inactivation of oipA also results in a decreased level of nuclear β-catenin  
in vitro and a reduced incidence of cancer in gerbils [84], indicative of the importance of this OMP in 
the virulence of H. pylori. Vaccination trials based on oral therapeutic immunization using  
OipA-DNA-based vaccines conferred effective protection against H. pylori challenge in mice with a 
strong Th1/Th2 immune response, eliminating H. pylori colonization in the stomach [90,91]. 
2.2.5. HopZ 
The hopZ (omp1) gene encodes a 74 kDa-protein (681 residues) located on the surface of the 
bacteria [92]. Immunofluorescence revealed that the HopZ variable region (amino-acids 126 to 281) is 
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exposed. HopZ involvement in adherence was demonstrated in vitro as a hopZ-knockout mutant strain 
showed significantly reduced binding capacity to the gastric epithelial AGS cell line, compared to the 
corresponding wild-type strain [61]. No receptor could be identified for this putative adhesin. In vivo 
the role of the HopZ protein in adherence and colonization is not clear. Indeed, lack of production of 
HopZ did not affect the ability of the bacteria to colonize the stomachs of guinea pigs [73], while 
genetic inactivation of hopZ reduced the ability of H. pylori to survive in the stomachs of gnotobiotic 
transgenic mice [93]. Two allelic variants (I and II) were reported for the hopZ gene [92] and 
recombination events occurred and led to the exchange of allele fragments [94]. Although hopQ 
(OMP27) is the closest to hopZ gene (Figure 1), no recombination event between these loci has been 
reported to date. 
The expression of the hopZ gene is regulated by SSM within CT dinucleotide repeats of different 
length localized at the 5' end of the coding region [92]. The HopZ switch status influenced both 
H. pylori density and its colonization ability in mice [61]. The hopZ “off” status frequently switches to 
“on” during human infection [95] and this status selected during early infection remains subsequently 
stable, suggesting a strong in vivo selection for this putative adhesin during early colonization [94]. 
The expression status of hopZ does not seem to correlate with the disease outcome, except for MALT 
lymphoma associated strains that appear to express a significantly smaller amount of the protein [95–97]. 
The hopZ “off” status was indeed associated with the development of MALT lymphoma [98]. 
2.2.6. HomB 
The smallest family of OMP is the Hom family constituted of four members. The most studied gene 
is homB encoding the HomB protein (~75 KDa) expressed in the H. pylori outer membrane [29]. 
homB has a closely related paralog, homA (Figure 1), sharing 90% sequence identity, especially at the 
5' and 3' ends with the differences between the two confined to the middle region of the respective 
open reading frames [24]. Allelic diversity was observed in the middle region of the genes, with six 
different alleles currently identified and expressed in vivo [99]. HomA/B variants likely occur via the 
accumulation of single nucleotide polymorphisms. No correlation between any allele and disease 
outcome was observed. For each gene, a dominant worldwide allele was detected (allele AII for homA 
and allele AI for homB), suggesting that homA/homB allelic variants are independent of the 
geographical origin of the strain. It was shown by an in silico approach that the most prevalent AI and 
AII alleles result from a homologous recombination between the rarest allelic variants of each gene, 
with a crossover point localized in the middle of the genes, containing the allelic region [100]. As for 
babA/babB, segment 3 (3' end) of homA/homB is under concerted evolution, in contrast to segment 1 
(5' end) which displays a divergent evolution [44,99]. homA/homB can also be present at multiple well 
conserved loci [24,99,101] and, although diversity regarding the number of copy does exist, there is a 
clear geographical specificity, suggesting an involvement of these genes in host adaptation. Furthermore, 
homA and homB sequence analysis also suggests regulation by phase variation [99]. 
HomB is present in the membrane of H. pylori and is antigenic in humans [29]. Moreover, the 
protein is associated with IL-8 secretion in vitro and contributes to bacterial adherence, both of these 
functions being correlated with the number of homB copies present in a strain [29] (Figure 2). In 
contrast to homA, homB is associated with the presence of cagA [29,102–104], as well as 
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inflammation and atrophy in the corpus [103]. It clearly appears that homB is a marker of more 
virulent H. pylori strains, which influences the severity of disease and contributes to more severe 
clinical outcomes. However, the exact involvement of HomB in the duodenal ulcer or gastric cancer 
outcome is not completely elucidated and is likely to be influenced by the geographical origin of the 
isolate [105,106]. Despite HomB’s role in adherence, a host receptor remains to be determined and 
will be a major challenge for future research. 
Figure 2. Involvement of the outer membrane protein HomB of Helicobacter pylori in 
interleukin 8 secretion and adherence to gastric epithelial AGS cells. 
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Cells were infected for 18 h with H. pylori clinical strains, wild-type (WT) and homB knockout mutant 
strains, single mutant (SM) and double mutant (DM) strains, at a multiplicity of infection of 100. (A) 
Adherence of H. pylori was determined by flow cytometry after bacteria labelling using the PKH2 green 
fluorescent linker kit (Sigma). Values denote the means of the triplicate (±SD). (Adapted from [29]). Two 
sequenced H. pylori strains 26695 (ATCC 700392) which were positive for homA and negative for homB, 
and J99 (ATCC 700824) which was positive for both homA and homB were used as reference  
strains [70,107]. Seven H. pylori clinical strains were used. The latter strains were all homA negative. The 
strain 417/02 contained 2 copies of homB at the homA and homB locus (GenBank accession nos. EF648377 
and EF648378, respectively). All of the other 6 strains carried a single copy of homB at the homB locus 
(strains 771/99, 1776/05, 559/02, 351/99, 36/00 and 565/99 (GenBank accession nos. EF648357, EF656577 
to EF656579, EF648369 and EF648370). DM, double mutant; NS, not significant; SM, single mutant; WT, 
wild-type. (B) Adherence of H. pylori wild-type (WT) and single homB knockout mutant (SM) strains to 
AGS cells. AGS cells were processed for fluorescent staining with fluorescent labelled-phalloidin to detect  
F-actin (red) and Hoechst 33342 compound to detect the nucleus (blue). Primary antibody followed by 
fluorescent labelled-secondary antibodies (green) was used to detect H. pylori. 
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3. Major Gastric Epithelial Receptors of H. pylori 
H. pylori exhibits both host tropism, exclusively colonizing humans and some primates, and tissue 
tropism, adhering only to the gastric epithelial lining of the antrum or staying in the gastric mucus 
layer. In the duodenum, gastric metaplasia is a pre-requisite for the presence of the bacterium, and 
reports exist of H. pylori colonization at distant sites of gastric metaplasia, such as in Meckel’s 
diverticula containing gastric mucosa and in the rectum [108,109]. In addition, H. pylori is not able to 
colonize areas of complete intestinal metaplasia in the gastric mucosa [110]. The majority of the 
bacteria remain in the mucus layer, with a smaller proportion colonizing the gastric surface.  
3.1. Lewis Blood Group Antigens 
H. pylori adheres to the mucus-secreting gastric epithelial cells of the lumen in the upper half of the 
gastric pit, but not to closely related mucus-secreting neck cells in the lower half of the gastric pit.  
H. pylori also does not adhere to chief cells, parietal cells, or endocrine cells in the gastric pit. 
The major component of the gastric mucus layer are the highly glycosylated mucin proteins. In a 
healthy gastric mucosa, the human mucins (MUC) produced include MUC1, MUC5AC and MUC6. 
The membrane associated MUC1 is expressed in foveolar cells; the secreted MUC5AC mucin, a major 
constituent of the surface mucus gel layer, is restricted to the foveolar epithelium; and finally the 
expression of the secreted MUC6 is limited to the neck cells of the glands. This mucin distribution 
establishes the gastric glycosylation pattern as the expression of MUC5AC is accompanied by a 
similar distribution of fucosyltransferases, leading to co-expression of type 1 antigens, Lea and Leb and 
H-type 1 blood group antigens. Blood group antigens are a group of carbohydrates typically found on 
erythrocytes, and also highly expressed in epithelial tissues, including the gastric mucosa. 
The fucosylated H-type 1 and Leb antigens are naturally expressed on the gastric mucosa of secretor 
or Lewis-positive individuals. The secretor status depends on an active α(1,2)-fucosyltransferase that 
catalyses the addition of terminal α(1,2)-fucose residues. On the other hand, MUC6 expression is 
associated with the type 2 antigens, Lex and Ley, which are consequently located deeper in the glands, 
e.g., in the mucus, chief and parietal acid-producing cells [111,112]. 
Studies show that H. pylori is very closely associated with extracellular MUC5AC and epithelial 
cells that produce MUC5AC, indicating that MUC5AC, but not MUC6, plays a role in the adherence 
of H. pylori to the gastric mucosa [113]. In addition MUC6 exhibits an antimicrobial activity [114]. 
The major receptor for H. pylori is the Leb carbohydrate structure present in the normal gastric  
tissue and MUC5AC is the most important carrier of Leb, with the attachment being made  
through BabA [115].  
Several studies demonstrated that the glycosylation pattern of gastric mucins differs between 
individuals and changes during gastric disease evolution within an individual, implying that H. pylori 
has to constantly adapt to these environmental modifications. A recent study evaluated the effect of 
glycan expression modifications in H. pylori adherence, by using the animal model of non-secretors, 
Fut2-null mice, which exhibit a reduced expression of α(1,2) fucosylated structures on their gastric 
mucosa. It was shown that strains expressing a functional BabA adhesin showed decreased adherence 
to the gastric mucosa of the Fut2-null mice, while the binding pattern of strains expressing only the 
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sialic acid-binding adhesin SabA was not altered, demonstrating that the impaired adherence could be 
attributed to reduced expression of BabA ligands in the gastric mucosa of Fut2-null mice [116]. 
3.2. Sialylated Glycans 
All H. pylori-infected individuals develop a chronic gastritis, with extensive inflammation of the 
mucosa, with a small fraction developing pre-neoplastic alterations such as atrophic gastritis and in a 
later stage intestinal metaplasia [117]. Under these clinical conditions, Leb is weakly expressed while 
there is an upward migration of Lex associated with atrophy of the epithelium. Moreover, inflammation 
of the gastric mucosa leads to the expression of sialylated glycans, such as sialyl-Lea and sialyl-Lex. In 
these cases, H. pylori will bind to sialyl-Lex via SabA adhesins [28]. Accordingly, it was demonstrated 
that SabA interaction with the host gastric sialyl-Lex antigen enhanced H. pylori colonization in 
patients with weak or no Leb expression [67]. 
4. The Importance of Adherence for Bacterial Colonization and Virulence  
H. pylori is very well adapted to its host and persists for decades in the human stomach. During an 
established infection, some of the H. pylori cells attach themselves directly to epithelial cells, while the 
vast majority of the cells (~70%) are found in the mucus layer of the superficial gastric mucosa, either 
motile or adhering to the heavily glycosylated secreted mucins. This location favours the acquisition of 
nutrients released from the damaged host cells and delivery of effector molecules into the gastric cell, 
such as the CagA oncoprotein and the VacA cytotoxin, while at the same time bacteria are prevented 
from being eliminated from the stomach by mucus turnover and gastric peristalsis. However, the tight 
adherence of H. pylori to the mucosa may be deleterious when host inflammatory and immune 
responses are robust. Thus, the bacteria must be able to manage, in a fast and effective way, the 
delicate balance between the adherent and the motile population. 
The importance of adherence to the colonization of the gastric niche has been highlighted by several 
studies showing a positive correlation between BabA-mediated adherence to Leb antigens and an 
increased bacterial colonization. Indeed, patients with gastric Leb expression had a higher bacterial 
density than those without Leb expression [118,119]. 
Even so, as explained previously, H. pylori adherence is not solely mediated by BabA-Leb 
interaction, as it can also be mediated by Lewis antigens other than Leb, such as Lea, Lex and its 
sialylated form, most likely via other adhesins [119]. Added proof is the fact that H. pylori can 
establish a chronic infection in both weak-secretor and non-secretor individuals as well, with these 
phenotypes estimated to affect nearly 20% of the human population [57,120,121]. In line with this, a 
study showed that BabA and SabA-negative strains could bind to gastric tissue in an AlpAB-dependent 
manner [22]. 
Several studies showed that adherence of H. pylori to the gastric mucosa plays a pivotal role in the 
outcome of infection. Indeed, the attachment of the bacterium to the epithelial cells induces signal 
transduction pathways in gastric cells, with activation of the transcription factor nuclear factor-κB. 
Subsequently, the cytokine IL-8 (an important T cell and neutrophil chemoattractant, and critical mediator 
in the H. pylori induced inflammatory process) is produced. One mode is through BabA-mediated binding 
to the host cells, which enables translocation of CagA, triggering a strong cytokine response. 
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Moreover, once translocated, CagA activates numerous host signaling pathways, inducing epithelial 
responses with carcinogenic potential, for a review see [122,123] and references cited therein (Figure 3). 
Figure 3. The role of bacterial adherence in Helicobacter pylori virulence. 
 
In the mucous layer, H. pylori binds to the apical membrane of gastric epithelial cells via BabA, SabA and 
other adhesins. The role H. pylori LPS in adherence to gastric epithelial cells is still unclear [19–22].  
H. pylori strains expressing a type IV secretion system (T4SS) encoded by the cag pathogenicity island are 
known to upregulate transcription factors such as the nuclear factor (NF)-κB, leading to production of  
pro-inflammatory cytokines and chemokines. Once adherent, H. pylori assembles T4SS pili (a needle-like 
pilus device) at their surface enabling the translocation of bacterial effector proteins into the cytoplasm of 
host gastric epithelial cells, such as the CagA oncoprotein and peptidoglycan. The intracellular delivery of 
CagA activates numerous host signaling pathways, inducing epithelial responses with carcinogenic potential. 
Leb, fucosylated Lewis b blood group antigen; S-Lex, sialyl-dimeric-Lewis x glycosphingolipid; LPS, 
lipopolysaccharide; P, phosphorylated; PG, peptidoglycan. 
The biological importance of the adhesin BabA-Leb receptor interaction on the pathogenic features 
of H. pylori has been highlighted in several studies [56,124]. Recently, it was shown both in vitro  
and in vivo that BabA-mediated binding of H. pylori to Leb on the epithelial surface increases  
T4SS-dependent H. pylori pathogenicity by triggering the production of proinflammatory cytokines 
CCL5 and IL-8 and the precancer-related factors, CDX2 and MUC2 [54]. 
The role of H. pylori attachment in the determination of clinical outcome has also been 
demonstrated by the epidemiological link between adherence-encoding genes and virulence 
determinants. In Western countries, clinical strains harbouring the triple genotype babA, cagA and the 
most virulent allele of vacA, the s1 allele, have been associated with duodenal ulcer and gastric 
adenocarcinoma [58,124,125]. The correlation of H. pylori adherence with inflammation and more 
severe disease outcome was also demonstrated for another less well studied OMP, HomB [102–104]. 
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In vitro co-culture assays on gastric epithelial AGS cells revealed that HomB contributes to bacterial 
adherence and induces activation of IL-8 secretion, depending on the number of homB copies present 
in a strain (Figure 2) [29]. 
A recent study explored how H. pylori is affected by the host, in particular by the host mucins, and 
what impact this regulation may have on the clinical outcome. The authors showed that mucin binding 
ability via BabA was an important factor for enhancing the H. pylori proliferation, with higher 
proliferation rates being observed with tumor-derived mucins and mucins from the surface mucosa, 
consisting mostly of MUC5AC, than with gland-derived mucins consisting mainly of MUC6 [126]. In 
addition, they showed that, in an adherence dependent manner, H. pylori responded to the presence of 
mucins with an upregulation of genes involved in colonization (babA, sabA, flaA and ureA) and 
virulence processes (cagA), suggesting once again that these genes are co-regulated in response to 
mucins. Therefore, the authors hypothesized that regulation of H. pylori by mucins may be an important 
explanation for individual variations in host response and symptoms following infection [126]. 
Besides the interaction of BabA adhesin and structural T4SS proteins in causing gastric lesions 
through CagA injection, it was shown, using the mouse model of infection, that the attachment of  
H. pylori to Leb led to an increase in the production of auto-antibodies to the host Lex antigens, 
produced either in bacterial LPS and in the acid-secreting parietal cells [127]. These data also suggests 
a significant impact of H. pylori adherence on the development of gastritis and gastric atrophy. 
5. Conclusions 
The gastric pathogen H. pylori has colonized the human stomach for more than two hundred 
thousand years and, despite a currently declining infection in developed western countries, it continues 
to spread among humans, with high incidence in developing countries in Asia and Africa. This 
unequivocal success as a pathogen/colonizer is due to complex strategies to maintain an inflammation 
of the gastric epithelium while limiting the extent of the immune response in order to prevent its 
elimination. One of the mechanisms contributing to an active host adaptation is without a doubt its 
adherence to the mucus layer and to the gastric epithelial cells, a complex phenotype involving 
multiple adhesins and different receptors whose availability changes according to inflammation and 
glycan expression at the epithelial surface. These molecules are all part of the vast repertoire of OMPs 
displayed by H. pylori strains, which are subjected to different mechanisms that alter and regulate their 
expression, therefore playing a role in the colonization of the bacteria, persistence of infection and 
ultimately in the severity of the associated disease. H. pylori adherence is far from being clear and 
future work should be carried out in search of additional adhesins as well as in clarifying the complex 
adherence-receptor network. Ultimately, these data should provide novel bacterial therapeutic or 
vaccine targets for the eradication of this persistent bacterium.  
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